Role of competitive endogenous RNA networks in the pathogenesis of coronary artery disease

Jiebin Zuo1, Mengxi Xu2, Danning Wang1

  • 1Cardiac Surgery and Structural Heart Disease Unit of Cardiovascular Center, The Fifth Affiliated Hospital Sun Yat-sen University, Zhuhai, China.

Abstract

Insights

This study constructed a competitive endogenous RNA (ceRNA) network to identify novel therapeutic targets for coronary artery disease (CAD). The network revealed key molecules and pathways involved in CAD pathogenesis, offering new treatment strategies.

Area of Science:

  • Genomics
  • Molecular Biology
  • Bioinformatics

Background:

  • Coronary artery disease (CAD) poses a significant global health challenge.
  • Understanding the molecular mechanisms underlying CAD pathogenesis is crucial for developing effective treatments.

Purpose of the Study:

  • To construct a competitive endogenous RNA (ceRNA) network associated with coronary artery disease (CAD).
  • To identify novel molecular targets for CAD treatment based on the ceRNA network.

Main Methods:

  • Utilized bioinformatics approaches to analyze gene expression datasets (GSE68506, GSE59421, GSE20129) from the Gene Expression Omnibus (GEO) database.
  • Employed databases such as miRcode, miRTarBase, miRDB, and TargetScan to predict interactions between long non-coding RNAs (lncRNAs), microRNAs (miRNAs), and messenger RNAs (mRNAs).
  • Constructed a comprehensive mRNA-miRNA-lncRNA ceRNA network for CAD using Cytoscape.

Main Results:

  • Identified significant numbers of differentially expressed lncRNAs (264), miRNAs (106), and mRNAs (1,879) between CAD and control groups.
  • The constructed ceRNA network comprised 21 DElncRNAs, 13 DEmiRNAs, and 143 DEmRNAs.
  • Key pathways implicated in CAD pathogenesis include PI3K-Akt and NF-κB signaling. Identified crucial genes within the protein-protein interaction network, including HSP90AA1, CDKN1A, and MCL1.

Conclusions:

  • The developed ceRNA network provides novel candidate molecules for CAD treatment.
  • Offers a more comprehensive and higher-quality basis for targeted therapeutic strategies in CAD.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
504
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
90
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.8K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.3K
Types of RNA01:20

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
7.0K